{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T06:12:24Z","timestamp":1783577544178,"version":"3.55.0"},"reference-count":30,"publisher":"BMJ","issue":"1","license":[{"start":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T00:00:00Z","timestamp":1762214400000},"content-version":"unspecified","delay-in-days":3,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"UK Research and Innovation Medical Research Council","award":["MR\/W014386\/1"],"award-info":[{"award-number":["MR\/W014386\/1"]}]},{"DOI":"10.13039\/501100023699","name":"Health Data Research UK","doi-asserted-by":"publisher","award":["HDR-23012"],"award-info":[{"award-number":["HDR-23012"]}],"id":[{"id":"10.13039\/501100023699","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012317","name":"UCLH Biomedical Research Centre","doi-asserted-by":"publisher","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}],"id":[{"id":"10.13039\/501100012317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/W014386\/1"],"award-info":[{"award-number":["MR\/W014386\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["220659\/Z\/20\/Z"],"award-info":[{"award-number":["220659\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["CL-2023-18-002"],"award-info":[{"award-number":["CL-2023-18-002"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","award":["MR\/V023373\/1"],"award-info":[{"award-number":["MR\/V023373\/1"]}],"id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIHR North Thames Applied Research Collaboration","award":["Not Applicable"],"award-info":[{"award-number":["Not Applicable"]}]}],"content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Ment Health"],"accepted":{"date-parts":[[2025,10,20]]},"published-print":{"date-parts":[[2025,11]]},"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>A higher prevalence of neurological conditions has been found in schizophrenia, bipolar disorder and other psychotic illnesses compared to the general population. We aimed to understand the cumulative prevalence of 15 neurological conditions in people with severe mental illness (SMI) from 5 years before to 5 years after their SMI diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>We identified patients with SMI, aged 18\u2013100 years from 1 Jan 2000 to 31 Dec 2018, from the UK Clinical Practice Research Datalink. Each SMI patient was matched 1:4 to individuals without SMI. The cumulative prevalence of 15 neurological conditions was recorded at 5, 3 and 1 years prior to SMI diagnosis; at SMI diagnosis; and 1, 3 and 5 years after SMI diagnosis. Prevalences were compared with logistic regression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>We identified 68\u2009789 patients with SMI and 274\u2009827 comparators. Of 15 neurological conditions, 13 (multiple sclerosis, cerebrovascular disease, dementia, ataxic disorders, epilepsy, Parkinson\u2019s disease, other parkinsonism, paralysis, other movement disorders, cerebrospinal fluid disorders, cerebral palsy, disorders of nerve root, plexus or peripheral nerves and autonomic disorders) were more prevalent in SMI compared with comparators at the time of SMI diagnosis. Dementia (OR: 4.22; 95% CI 3.88 to 4.58), epilepsy (OR: 3.01; 95% CI 2.83 to 3.19) and Parkinson\u2019s disease (OR: 3.97; 95% CI 3.45 to 4.57) were particularly elevated at 5 years post-SMI diagnosis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Many neurological conditions have higher prevalence in the SMI cohort compared with those without SMI. The different prevalence patterns observed in our study highlight the need to establish the causal pathways between specific SMI and neurological disease diagnoses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1136\/bmjment-2025-301923","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:45:39Z","timestamp":1762325139000},"page":"e301923","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":3,"title":["Temporal relationship between severe mental illness and neurological conditions in a UK primary care cohort"],"prefix":"10.1136","volume":"28","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1674-8844","authenticated-orcid":false,"given":"Ella","family":"Burchill","sequence":"first","affiliation":[{"name":"Division of Psychiatry, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4671-5410","authenticated-orcid":false,"given":"Jonathan P","family":"Rogers","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, University College London, London, UK"},{"name":"Department of Neuropsychiatry, National Hospital for Neurology and Neurosurgery, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2519-1539","authenticated-orcid":false,"given":"David P J","family":"Osborn","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, University College London, London, UK"},{"name":"North London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5205-8245","authenticated-orcid":false,"given":"Glyn","family":"Lewis","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, University College London, London, UK"},{"name":"North London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0967-774X","authenticated-orcid":false,"given":"Anthony S","family":"David","sequence":"additional","affiliation":[{"name":"Institute of Mental Health, Division of Psychiatry, University College London Faculty of Brain Sciences, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2286-3862","authenticated-orcid":false,"given":"Joseph F","family":"Hayes","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, University College London, London, UK"},{"name":"North London NHS Foundation Trust, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4241-938X","authenticated-orcid":false,"given":"Naomi","family":"Launders","sequence":"additional","affiliation":[{"name":"Division of Psychiatry, University College London, London, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2025,11,4]]},"reference":[{"key":"2025110422452258000_28.1.e301923.1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychires.2022.02.036"},{"key":"2025110422452258000_28.1.e301923.2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1915784"},{"key":"2025110422452258000_28.1.e301923.3","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/eurheartj\/ehae054","article-title":"Severe mental illness: cardiovascular risk assessment and management","volume":"45","author":"Polcwiartek","year":"2024","journal-title":"Eur Heart J"},{"key":"2025110422452258000_28.1.e301923.4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1192\/bja.2024.52","article-title":"Metabolic dysfunction in severe mental illness: updates on prevalence, aetiology and treatment options","volume":"31","author":"Needham","year":"2025","journal-title":"BJPsych advances"},{"key":"2025110422452258000_28.1.e301923.5","doi-asserted-by":"publisher","DOI":"10.1177\/0269881116645254"},{"key":"2025110422452258000_28.1.e301923.6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1017\/S1092852915000929","article-title":"Comorbidity between neurological illness and psychiatric disorders","volume":"21","author":"Hesdorffer","year":"2016","journal-title":"CNS Spectr"},{"key":"2025110422452258000_28.1.e301923.7","first-page":"11","article-title":"Editorial: mental disorders associated with neurological diseases","volume":"11","author":"Yang","year":"2020","journal-title":"Front Psychiatry"},{"key":"2025110422452258000_28.1.e301923.8","doi-asserted-by":"crossref","unstructured":"Mirza L , Das-Munshi J , Chaturvedi J , et al . Investigating the association between physical health comorbidities and disability in individuals with severe mental illness. Eur Psychiatr 2021;64. doi:10.1192\/j.eurpsy.2021.2255","DOI":"10.1192\/j.eurpsy.2021.2255"},{"key":"2025110422452258000_28.1.e301923.9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/S2215-0366(22)00225-5","article-title":"The temporal relationship between severe mental illness diagnosis and chronic physical comorbidity: a UK primary care cohort study of disease burden over 10 years","volume":"9","author":"Launders","year":"2022","journal-title":"Lancet Psychiatry"},{"key":"2025110422452258000_28.1.e301923.10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/acps.12733","article-title":"The \u201ccognitive footprint\u201d of psychiatric and neurological conditions: cross-sectional study in the UK Biobank cohort","volume":"135","author":"Cullen","year":"2017","journal-title":"Acta Psychiatr Scand"},{"key":"2025110422452258000_28.1.e301923.11","doi-asserted-by":"crossref","first-page":"612084","DOI":"10.3389\/fpsyt.2020.612084","article-title":"Health conditions and psychotic experiences: cross-sectional findings from the american life panel","volume":"11","author":"Oh","year":"2020","journal-title":"Front Psychiatry"},{"key":"2025110422452258000_28.1.e301923.12","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2009.08.014"},{"key":"2025110422452258000_28.1.e301923.13","doi-asserted-by":"publisher","DOI":"10.1136\/practneurol-2017-001775"},{"key":"2025110422452258000_28.1.e301923.14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.5498\/wjp.v12.i4.580","article-title":"Effects of antiseizure medications on alternative psychosis and strategies for their application","volume":"12","author":"Yan","year":"2022","journal-title":"World J Psychiatry"},{"key":"2025110422452258000_28.1.e301923.15","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1093\/brain\/aww196","article-title":"Psychotic disorders induced by antiepileptic drugs in people with epilepsy","volume":"139","author":"Chen","year":"2016","journal-title":"Brain (Bacau)"},{"key":"2025110422452258000_28.1.e301923.16","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s12311-017-0882-5","article-title":"Psychosis in spinocerebellar ataxias: a case series and study of tyrosine hydroxylase in substantia Nigra","volume":"17","author":"Turk","year":"2018","journal-title":"Cerebellum"},{"key":"2025110422452258000_28.1.e301923.17","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1176\/appi.ajp.2008.08020285","article-title":"Schizophrenia in a patient with spinocerebellar ataxia 2: coincidence of two disorders or a neurodegenerative disease presenting with psychosis?","volume":"165","author":"Rottnek","year":"2008","journal-title":"AJP"},{"key":"2025110422452258000_28.1.e301923.18","doi-asserted-by":"crossref","first-page":"93","DOI":"10.4103\/0972-2327.144285","article-title":"Spinocerebellar ataxia-10 with paranoid schizophrenia","volume":"18","author":"Trikamji","year":"2015","journal-title":"Ann Indian Acad Neurol"},{"key":"2025110422452258000_28.1.e301923.19","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1176\/appi.ajp.2011.11050737","article-title":"New-onset psychosis in a patient with spinocerebellar ataxia type 10","volume":"168","author":"Wexler","year":"2011","journal-title":"AJP"},{"key":"2025110422452258000_28.1.e301923.20","doi-asserted-by":"crossref","unstructured":"Chen K-H , Lin C-H , Wu R-M . Psychotic-affective symptoms and multiple system atrophy expand phenotypes of spinocerebellar ataxia type 2. BMJ Case Rep 2012;2012. doi:10.1136\/bcr.10.2011.5061","DOI":"10.1136\/bcr.10.2011.5061"},{"key":"2025110422452258000_28.1.e301923.21","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s12311-015-0716-2","article-title":"Psychosis in Machado\u2013Joseph disease: clinical correlates, pathophysiological discussion, and functional brain imaging. expanding the cerebellar cognitive affective syndrome","volume":"15","author":"Braga-Neto","year":"2016","journal-title":"Cerebellum"},{"key":"2025110422452258000_28.1.e301923.22","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.aje.a009786"},{"key":"2025110422452258000_28.1.e301923.23","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-019-05907-4"},{"key":"2025110422452258000_28.1.e301923.24","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.2009.03537.x"},{"key":"2025110422452258000_28.1.e301923.25","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-021-01161-7"},{"key":"2025110422452258000_28.1.e301923.26","doi-asserted-by":"publisher","DOI":"10.1038\/s41380-019-0569-z"},{"key":"2025110422452258000_28.1.e301923.27","doi-asserted-by":"crossref","first-page":"3392","DOI":"10.1093\/brain\/awad038","article-title":"Identification of novel genomic risk loci shared between common epilepsies and psychiatric disorders","volume":"146","author":"Karadag","year":"2023","journal-title":"Brain (Bacau)"},{"key":"2025110422452258000_28.1.e301923.28","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1017\/S1041610217000874","article-title":"Psychosis and dementia: risk factor, prodrome, or cause?","volume":"30","author":"Fischer","year":"2018","journal-title":"Int Psychogeriatr"},{"key":"2025110422452258000_28.1.e301923.29","doi-asserted-by":"publisher","DOI":"10.1002\/ana.21995"},{"key":"2025110422452258000_28.1.e301923.30","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-013-6905-3"}],"container-title":["BMJ Mental Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bmjment-2025-301923","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T06:45:48Z","timestamp":1762325148000},"score":1,"resource":{"primary":{"URL":"https:\/\/mentalhealth.bmj.com\/lookup\/doi\/10.1136\/bmjment-2025-301923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,11,4]]},"published-print":{"date-parts":[[2025,11]]}},"alternative-id":["10.1136\/bmjment-2025-301923"],"URL":"https:\/\/doi.org\/10.1136\/bmjment-2025-301923","relation":{},"ISSN":["2755-9734"],"issn-type":[{"value":"2755-9734","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}